Increases in CD4 T Lymphocytes with Intermittent Courses of Interleukin-2 in Patients with Human Immunodeficiency Virus Infection — A Preliminary Study

Authors:
  • MBMichael Baseler
    Michael Baseler
  • RDRobin J. Dewar
    Robin J. Dewar
  • SVSusan Vogel
    Susan Vogel
  • RDRichard T. Jr. Davey
    Richard T. Jr. Davey
  • JFJudith Falloon
    Judith Falloon
  • RWRobert E. Walker
    Robert E. Walker
  • RSRandy Stevens
    Randy Stevens
  • NSNorman P. Salzman
    Norman P. Salzman
  • JMJulia A. Metcalf
    Julia A. Metcalf
  • HMHenry Masur
    Henry Masur

Abstract
Interleukin-2 is an important regulatory cytokine of the immune system, with potent effects on T cells, B cells, and natural killer cells. In vitro, interleukin-2 can induce the proliferation and differentiation of peripheral-blood mononuclear cells from patients infected with the human immunodeficiency virus (HIV).

This publication has 41 references indexed in Scilit: